| scholarly article | Q13442814 |
| P50 | author | Marlus Chorilli | Q38801377 |
| Fernando R. Pavan | Q39482718 | ||
| P2093 | author name string | Débora L Campos | |
| Patricia B da Silva | |||
| Paula C de Souza | |||
| Mariana R Sato | |||
| João A Oshiro Junior | |||
| Rachel Ta Machado | |||
| P2860 | cites work | Co(II) and Cu(II) pyrophosphate complexes have selectivity and potency against Mycobacteria including Mycobacterium tuberculosis | Q86694020 |
| The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages | Q24561597 | ||
| Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease | Q26783306 | ||
| Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy | Q33238084 | ||
| Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study. | Q33924942 | ||
| Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis | Q34510604 | ||
| Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation | Q34976354 | ||
| Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations | Q35013521 | ||
| Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp | Q35954636 | ||
| Copper-boosting compounds: a novel concept for antimycobacterial drug discovery | Q36558441 | ||
| In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis. | Q36939307 | ||
| Novel Zinc(II) Complexes [Zn(atc-Et)₂] and [Zn(atc-Ph)₂]: In Vitro and in Vivo Antiproliferative Studies. | Q36939375 | ||
| Nanostructured lipid carriers system: recent advances in drug delivery. | Q38038902 | ||
| Novel drugs against tuberculosis: a clinician's perspective. | Q38272243 | ||
| Recent advances in nanoparticle carriers for coordination complexes. | Q38314555 | ||
| Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives | Q38628369 | ||
| Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies. | Q38799846 | ||
| A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes | Q38809156 | ||
| Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. | Q39335226 | ||
| Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis | Q39482623 | ||
| Molecular interaction and localization of tocotrienol-rich fraction (TRF) within the matrices of lipid nanoparticles: evidence studies by Differential Scanning Calorimetry (DSC) and Proton Nuclear Magnetic Resonance spectroscopy ((1)H NMR). | Q39896630 | ||
| Synthesis and Biological Evaluation of New Hydrazone Derivatives of Quinoline and Their Cu(II) and Zn(II) Complexes against Mycobacterium tuberculosis | Q42112653 | ||
| Spectroscopic, magnetic and thermal studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes of 3-acetylcoumarin–isonicotinoylhydrazone and their antimicrobial and anti-tubercular activity evaluation | Q42910299 | ||
| Preservation of nanostructured lipid carriers (NLC). | Q44447009 | ||
| Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. | Q46080514 | ||
| Nanostructured lipid systems as a strategy to improve the in vitro cytotoxicity of ruthenium(II) compounds. | Q47644894 | ||
| Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study. | Q47822279 | ||
| A rapid, simple, and humane method for submandibular bleeding of mice using a lancet | Q48773146 | ||
| Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea. | Q50513280 | ||
| Nanostructured lipid matrices for improved microencapsulation of drugs. | Q52956179 | ||
| Atomic force microscopy studies of solid lipid nanoparticles. | Q53005144 | ||
| The effect of oil type on the aggregation stability of nanostructured lipid carriers. | Q53633135 | ||
| The role of modulated temperature differential scanning calorimetry in the characterisation of a drug molecule exhibiting polymorphic and glass forming tendencies | Q73205778 | ||
| Handbook of anti-tuberculosis agents. Introduction | Q81294000 | ||
| Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles | Q84036617 | ||
| Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? | Q84289722 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 909-921 | |
| P577 | publication date | 2017-03-20 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis | |
| P478 | volume | 11 |
Search more.